search
Back to results

Information Support Using an Online Learning Platform for Malaysian Pediatric Leukemia and Lymphoma Parents (eHOPE)

Primary Purpose

Pediatric Acute Myeloid Leukemia, Pediatric Acute Lymphoid Leukemia, Pediatric Non-Hodgkin Lymphoma

Status
Completed
Phase
Not Applicable
Locations
Malaysia
Study Type
Interventional
Intervention
eHOPE
Usual care
Sponsored by
Universiti Kebangsaan Malaysia Medical Centre
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Pediatric Acute Myeloid Leukemia focused on measuring Information support, Online learning, Parent, Feasibility, Caregiver education, Self-efficacy, Knowledge

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Child (age <18 years) is diagnosed with either leukemia or lymphoma in the 3 months preceding recruitment
  • Child is receiving care from either study site
  • Able to access internet for health information via a computer, tablet or a mobile device
  • Able to read and understand Malay language

Exclusion Criteria:

  • Child is transferred to other hospital for continuation of treatment
  • Extreme psychological distress
  • Partner or spouse already enrolled into the current trial

Sites / Locations

  • Hospital Tunku Azizah
  • Hospital Tunku Ampuan Besar Tuanku Aishah Rohani Hospital Pakar Kanak-kanak UKM (HPKK)

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

eHOPE

Usual care

Arm Description

Participants in the intervention group will receive access to e-Hematological Oncology Parent Education (eHOPE) and usual care. Participants will need to complete 4 self-paced activities over a period of 8 weeks. Each activity will be released at 2-weekly intervals.

Participants in the waitlist-control group will receive verbal explanations and caregiver education based on clinician's needs assessment in the course of their child's treatment process. At the end of 8-weeks, they will also receive access to eHOPE.

Outcomes

Primary Outcome Measures

Change from baseline caregiving knowledge at 8 weeks
This will be measured by the Hematological Oncology Parent's Education Caregiving Knowledge Questionnaire (HOPE-CKQ), a newly developed and validated 18-item Malay language questionnaire. The scale has a possible score range of 0-18. Higher scores will indicate better knowledge.
Recruitment rate
This will be calculated as the number of participants recruited and randomized per centre per month.
Dropout rate
This will be calculated as the proportion of participants who did not complete the trial over the total number of participants who were recruited and randomized.

Secondary Outcome Measures

Change from baseline family caregiving self-efficacy at 8 weeks
Based on scores of the Family Caregiving Activation in Transitions tool, a 10-item 6-point Likert scale with possible scores of 6 to 60. Higher scores indicate better caregiving self-efficacy.
Change from baseline coping self-efficacy at 8 weeks
Based on scores of the Coping Self-Efficacy tool, a 26-item 11-point Likert scale with possible scores of 0 to 260. Higher scores denote better coping self-efficacy.

Full Information

First Posted
June 27, 2022
Last Updated
May 8, 2023
Sponsor
Universiti Kebangsaan Malaysia Medical Centre
Collaborators
Universiti Putra Malaysia, Ministry of Health, Malaysia
search

1. Study Identification

Unique Protocol Identification Number
NCT05455268
Brief Title
Information Support Using an Online Learning Platform for Malaysian Pediatric Leukemia and Lymphoma Parents
Acronym
eHOPE
Official Title
Feasibility of e-Hematology Oncology Parents Education (eHOPE) for Information Support Among Malaysian Parents of Children With Hematological Cancer
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Completed
Study Start Date
July 15, 2022 (Actual)
Primary Completion Date
March 31, 2023 (Actual)
Study Completion Date
March 31, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Universiti Kebangsaan Malaysia Medical Centre
Collaborators
Universiti Putra Malaysia, Ministry of Health, Malaysia

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This is a study protocol to determine whether it is feasible to support parents of children with blood cancers by providing information over an online learning platform. This study will be conducted in Malaysia. An online learning platform will be used to provide information relevant to parents who care for children diagnosed with leukemia or lymphoma. The use of this platform will be compared with current usual care, where only verbal discussions and ad hoc caregiver training is provided to support these parents, based on the clinician's judgement. Participants knowledge and confidence level in caregiving as well as coping will be compared between the two groups. To determine the feasibility of this method of information support, the researchers will also obtain feedback from participants who used the online learning platform and determine whether there are many who drop out from using it. The findings will determine whether use of online learning platform is suitable to deliver information support for parents, in view of currently limited resources for supportive care in childhood cancer care in Malaysia.
Detailed Description
This is the study protocol for a multi-centre interventional open-label randomized controlled feasibility trial to evaluate the feasibility of delivering informational support via an online learning platform to Malaysian parents of children with leukemia or lymphoma. The study will be conducted in two pediatric oncology centres in Kuala Lumpur, Malaysia. Study participants will include adult parents of children who were diagnosed with leukemia or lymphoma in the preceding 3. Block randomization will be used to allocate participants into the intervention or a waitlist-control arm. The intervention group will receive access to e-Hematological Oncology Parent Education (eHOPE), which provides information support for parents in the local Malay language, via an online learning platform. They will also receive usual care, which includes verbal explanations and caregiver education in the course of their child's treatment process. Parents will be able to access multimedia information designed to support them in the care of their sick child, and will need to complete 4 self-paced activities over a period of 8 weeks. The waitlist-control group will receive usual care, and at the end of 8 weeks, will also receive access to eHOPE. The primary outcome of this trial will be the change in caregiving knowledge, whereas secondary outcomes include caregiving self-efficacy and coping self-efficacy. Descriptive data on feasibility will include duration of recruitment to achieve targeted sample size, the drop-out rate of participants and identified barriers to implementation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pediatric Acute Myeloid Leukemia, Pediatric Acute Lymphoid Leukemia, Pediatric Non-Hodgkin Lymphoma, Pediatric Hodgkin Lymphoma
Keywords
Information support, Online learning, Parent, Feasibility, Caregiver education, Self-efficacy, Knowledge

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Participants for both the intervention and control arms will be recruited simultaneously and allocated using block randomisation to achieve fairly equal numbers of participants in both study sites. At the end of the 8-week intervention period, participants in the waitlist control arm will receive access to the intervention.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
51 (Actual)

8. Arms, Groups, and Interventions

Arm Title
eHOPE
Arm Type
Experimental
Arm Description
Participants in the intervention group will receive access to e-Hematological Oncology Parent Education (eHOPE) and usual care. Participants will need to complete 4 self-paced activities over a period of 8 weeks. Each activity will be released at 2-weekly intervals.
Arm Title
Usual care
Arm Type
Active Comparator
Arm Description
Participants in the waitlist-control group will receive verbal explanations and caregiver education based on clinician's needs assessment in the course of their child's treatment process. At the end of 8-weeks, they will also receive access to eHOPE.
Intervention Type
Other
Intervention Name(s)
eHOPE
Intervention Description
e-Haematological Oncology Parents Education (eHOPE) consists of caregiving information for parents of children with leukaemia and lymphoma, presented in multimedia format through an online learning platform. The contents are developed in Malay language, encompassing basic information on disease and treatment, medical caregiving, emotional caregiving, appraising information, communication and self-care. Parents will be able to access multimedia information designed to support them in the care of their sick child. There are 4 self-paced activities in eHOPE with the following objectives: Parents should be able to outline key tasks related to care for their child at home. Parents should be able to outline strategies to initiate discussions with their child's healthcare providers. Parents should be able to appraise reliability of information sources. Parents should be able to identify coping strategies that they can use when faced with stressful situations.
Intervention Type
Other
Intervention Name(s)
Usual care
Intervention Description
Face-to-face verbal discussions and caregiver training will be provided as deemed necessary by the clinicians.
Primary Outcome Measure Information:
Title
Change from baseline caregiving knowledge at 8 weeks
Description
This will be measured by the Hematological Oncology Parent's Education Caregiving Knowledge Questionnaire (HOPE-CKQ), a newly developed and validated 18-item Malay language questionnaire. The scale has a possible score range of 0-18. Higher scores will indicate better knowledge.
Time Frame
At baseline and at 8 weeks
Title
Recruitment rate
Description
This will be calculated as the number of participants recruited and randomized per centre per month.
Time Frame
Through study completion, an average of 8 months
Title
Dropout rate
Description
This will be calculated as the proportion of participants who did not complete the trial over the total number of participants who were recruited and randomized.
Time Frame
Through study completion, an average of 8 months
Secondary Outcome Measure Information:
Title
Change from baseline family caregiving self-efficacy at 8 weeks
Description
Based on scores of the Family Caregiving Activation in Transitions tool, a 10-item 6-point Likert scale with possible scores of 6 to 60. Higher scores indicate better caregiving self-efficacy.
Time Frame
At baseline and at 8 weeks.
Title
Change from baseline coping self-efficacy at 8 weeks
Description
Based on scores of the Coping Self-Efficacy tool, a 26-item 11-point Likert scale with possible scores of 0 to 260. Higher scores denote better coping self-efficacy.
Time Frame
At baseline and at 8 weeks.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Child (age <18 years) is diagnosed with either leukemia or lymphoma in the 3 months preceding recruitment Child is receiving care from either study site Able to access internet for health information via a computer, tablet or a mobile device Able to read and understand Malay language Exclusion Criteria: Child is transferred to other hospital for continuation of treatment Extreme psychological distress Partner or spouse already enrolled into the current trial
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Chai Eng Tan
Organizational Affiliation
National University of Malaysia
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital Tunku Azizah
City
Kuala Lumpur
ZIP/Postal Code
50300
Country
Malaysia
Facility Name
Hospital Tunku Ampuan Besar Tuanku Aishah Rohani Hospital Pakar Kanak-kanak UKM (HPKK)
City
Kuala Lumpur
ZIP/Postal Code
56000
Country
Malaysia

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
Due to requirements of the respective ethical committees, individual participant data will not be made available to other researchers. However, reasonable request for deidentified participant data may be considered by the principal investigator on case-to-case basis.
Citations:
PubMed Identifier
35494095
Citation
Tan CE, Lau SCD, Latiff ZA, Lee CC, Teh KH, Sidik SM. Information needs of Malaysian parents of children with cancer: A qualitative study. Asia Pac J Oncol Nurs. 2021 Dec 25;9(3):143-152. doi: 10.1016/j.apjon.2021.11.001. eCollection 2022 Mar.
Results Reference
background

Learn more about this trial

Information Support Using an Online Learning Platform for Malaysian Pediatric Leukemia and Lymphoma Parents

We'll reach out to this number within 24 hrs